Pharma News

Ajanta Pharma posted satisfactory financial performance for the fourth quarter ended March 2015 and its standalone net profit increased by 20.3 per cent to Rs. 84.31 crore from Rs. 70.09 crore in the corresponding period of last year. EBIDTA increased by 22 per cent to Rs. 140.72 crore from Rs. 115.36 crore. Its net sales rise up by 19.7 per cent to Rs. 360.36 crore from Rs. 301.14 crore. Export is 67 per cent of the revenue for the quarter. R&D expenditure increased to Rs. 24 crore from Rs. 11 crore in the similar period of last year. The board of directors has approved equity share of 300 per cent for the year 2014-15.

GlaxoSmithKline (GSK), has posted net profit of  £8,038 million during the first quarter ended March 2015 as against £719 million in the corresponding period of last year, mainly due to other operating income of £8,712 million. Its sales remained almost stagnant at £5,622 million as compared to £5,613 million. Its R&D expenditure increased to £867 million from £859 million.

[adsense:336x280:8701650588]

Mylan NV, a global pharmaceutical company, launched levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg, generic version of Teva's Seasonale tablets, in the US.

CyMedica Orthopedics, Inc.,  has commercially launched the CyMedica QB1 System for the treatment of quadriceps muscle atrophy. The CyMedica QB1 System has introduced at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine (AANA) annual meeting in Los Angeles recently.

Biocon, a leading innovation-led bio-pharmaceutical company, has announced satisfactory financial performance during the fourth quarter ended March 2014. Its consolidated net profit, after exceptional income of Rs. 105 crore on account of sale of Syngene shares, increased by 78.2 per cent to Rs. 201.54 crore from Rs. 113.08 crore in the corresponding period of last year. Operating profit jumped 4.7 percent year-on-year to Rs 202 crore for the quarter ended March 2015 from Rs 193 crore in the same quarter last year.Profit before tax and exceptional income also improved by only 4 per cent to Rs. 143.54 crore from Rs. 138.06 crore. EPS moved up to Rs. 10.08 from Rs. 5.76 crore.  Its consolidated net sales increased by 14.9 per cent to Rs. 830.38 crore during the fourth quarter from Rs. 722.59 crore in the same period of last year. Its pharma sales increased by 10.8 per cent to Rs. 594.91 crore from Rs. 536.77 crore and that of contract research & manufacturing services improved by 27.7 per cent to Rs. 248.92 crore from Rs. 194.90 crore.

In Maharashtra doctors demanding for simplification of F-Form of Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act. Filling-up of F-Form a tedious and lengthy job. F-Form is an important document for maintaining the record in case of prenatal diagnostic test/procedure by genetic clinic/ultrasound clinic and imaging centre.

Bosch Packaging _Technology, one of the leading suppliers introduce the new granulation unit, GranuLean at Achema 2015 to be held in Germany from June 15 to 19, 2015. It ranges from filling, processing, and packaging technology for piece goods and bulk items in the food, pharmaceutical, and confectionery sectors as well as for health and hygiene products.

Researchers studying the commonly used pain reliever acetaminophen or paracetamol have found that it has a previously unknown side effect: it blunts positive emotions. In the study, participants who took acetaminophen reported less strong emotions when they saw both very pleasant and very disturbing photos, when compared to those who took placebos.